NAFTIFINE HYDROCHLORIDE
| Brand name | NAFTIN |
|---|---|
| Active ingredient | NAFTIFINE HYDROCHLORIDE |
| Strength | 2% |
| Dosage form | GEL |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | June 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9161914 | January 2033 | use U-540 |
| 10729667 | January 2033 | product |
| 8778365 | January 2033 | product |
| 10695303 | January 2033 | product |
| 10166206 | January 2033 | product |
| 10166205 | January 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.